[1. Horna P., Zhang L., Sotomayor E.M., Lancet J.E., Moscinski L.C. Diagnostic Immunophenotype Of Acute Promyelocytic Leukemia Before And Early During Therapy With All-Trans Retinoic Acid. Am J Clin Pathol. 2014; 142(4):546-52.10.1309/AJCPPOKEHBP53ZHV574486325239423]Search in Google Scholar
[2. Carella A.M., Antonucci G., Conte M., Di Pumpo M., Antonucci E., Ponziano E. A Case Of Ischemic Stroke In Acute Promyelocytic Leukemia At Initial Presentation. Relevance Of All-Trans Retinoic Acid Treatment. Cardiovasc Hematol Disord Drug Targets. 2010; 10(1):1-6.10.2174/18715291079078006920041837]Search in Google Scholar
[3. Falanga A., Barbui T. Coagulopathy Of Acute Promyelocytic Leukemia. Acta Haematol. 2001; 106(1-2):43-51.10.1159/00004658811549776]Search in Google Scholar
[4. Sanz M, Grimwade D., Tallman M.S., Lowenberg B., Fenaux P., Estey E.H. Et Al. Management Of Acute Promyelocytic Leukemia: Recommendations From An Expert Panel On Behalf Of The European Leukemianet. Blood. 2009; 113(9):1875-91.10.1182/blood-2008-04-15025018812465]Search in Google Scholar
[5. Kapoor R., Pati H.P., Gupta S.K., Gupta N. Acute Promyelocytic Leukemia Presenting As Ischemic Stroke In Young. Indian J Hematol Blood Transfus. 2013; 29(2):93-5.10.1007/s12288-012-0145-z363634624426346]Search in Google Scholar
[6. Quadir T.A., Dhabhar B.N., Dhar A.K., Hedge U.P., Shah R.V., Pathak A.B. Et Al. Acute Promyelocytic Leukemia With Ischaemic Events. J Assoc Physicians India. 1993; 41(5):300-2.]Search in Google Scholar
[7. Saitoh E., Sugita K., Kurosawa H., Kurosaki M., Eguchi M., Furukawa T. Et Al. Cerebral Infarction In Acute Promyelocytic Leukemia At Initial Presentation. Acta Paediatr Jpn Overseas Ed. 1995; 37(6):710-2.10.1111/j.1442-200X.1995.tb03411.x]Search in Google Scholar
[8. De Stefano V., Sora F., Rossi E., Chiusolo P., Laurenti L., Fianchi L. Et Al. The Risk Of Thrombosis In Patients With Acute Leukemia: Occurrence Of Thrombosis At Diagnosis And During Treatment. J Thromb Haemost. 2005; 3:1985-92.10.1111/j.1538-7836.2005.01467.x16102104]Search in Google Scholar
[9. Lou Y., Mai W., Jin J. Simultaneous Presentation Of Acute Myocardial Infarction And Acute Promyelocytic Leukemia. Ann Hematol. 2006; 85(6):409-10.10.1007/s00277-006-0106-416557379]Search in Google Scholar
[10. Runde V., Aul C., Heyll A., Schneider W. All-Trans Retinoic Acid: Not Only A Differentiating Agent, But Also An Inducer Of Thromboembolic Events In Patients With M3 Leukemia. Blood.1992; 79(2):534-5.10.1182/blood.V79.2.534.534]Search in Google Scholar
[11. Escudier S.M., Kantarjian H.M., Estey E.H. Thrombosis In Patients With Acute Promyelocytic Leukemia Treated With And Without All-Trans Retinoic Acid. Leuk Lymphoma. 1996; 20(5-6):435-9.10.3109/104281996090524258833399]Search in Google Scholar
[12. Kim T., Shatzel J., Friedman H., Lansigan F. The Epidemiology And Clinical Associations Of Stroke In Patients With Acute Myeloid Leukemia: A Review Of 10,972 Admissions From The 2012 National Inpatient Sample. Blood. 2015; 126(23).10.1182/blood.V126.23.1314.1314]Search in Google Scholar
[13. Barbui T., Finazzi G., Falanga A. The Impact Of All-Trans-Retinoic Acid On The Coagulopathy Of Acute Promyelocytic Leukemia. Blood. 1998; 91(9):3093-102.10.1182/blood.V91.9.3093]Search in Google Scholar
[14. Menell J.S., Cesarman G.M., Jacovina A.T., Mclaughlin M.A., Lev E.A., Hajjar K.A. Annexin Ii And Bleeding In Acute Promyelocytic Leukemia. N Engl J Med.1999; 340(13):994-1004.10.1056/NEJM19990401340130310099141]Search in Google Scholar